⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Belupo d.d. and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Belupo d.d.
↗Koprivnica, Croatia
Belupo d.d. is a leading Croatian pharmaceutical company headquartered in Koprivnica, founded in 1971. It operates as a subsidiary of the Podravka Group and specializes in the production and distribution of prescription drugs, over-the-counter (OTC) products, herbal medicines, dietary supplements, and cosmetics.
The company maintains a strong presence in Central, Eastern, and Southeastern Europe, operating in 18+ pharmaceutical markets. Belupo is particularly recognized for its leadership in cardiovascular and dermatological therapeutic programs and is committed to high standards of Good Manufacturing Practice (GMP) and digital transformation in its manufacturing processes.
CLASSIFICATION
SIZE & FINANCIALS
Employees:1001-5000
Revenue:$100M-$200M
Founded:1971
Ownership:subsidiary
Status:operating
FUNDING
Investors:Podravka d.d. (Parent Company)
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Small molecule
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:Podravka d.d.
Subsidiaries:Belupo d.o.o. (Slovenia), Belupo s.r.o. (Slovakia), Belupo Dooel Skopje (North Macedonia)
Key Partnerships:Podravka Group (Parent), Rudjer Boskovic Institute (R&D collaboration)
COMPETITION
Position:Leader
Competitors:Pliva, Jadran Galenski Laboratorij (JGL), Krka, PharmaS
LEADERSHIP
Key Executives:
Hrvoje Ceovic - CEO and President of the Management Board
LINKS
Website:belupo.hr
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Belupo d.d.. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.